398 related articles for article (PubMed ID: 18201950)
41. Particulate matter increases beta-amyloid and activated glial cells in hippocampal tissues of transgenic Alzheimer's mouse: Involvement of PARP-1.
Jang S; Kim EW; Zhang Y; Lee J; Cho SY; Ha J; Kim H; Kim E
Biochem Biophys Res Commun; 2018 Jun; 500(2):333-338. PubMed ID: 29654761
[TBL] [Abstract][Full Text] [Related]
42. Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid β-Protein Oligomers.
Xu H; Gelyana E; Rajsombath M; Yang T; Li S; Selkoe D
J Neurosci; 2016 Aug; 36(35):9041-56. PubMed ID: 27581448
[TBL] [Abstract][Full Text] [Related]
43. Neuroinflammation in Alzheimer's Disease: The Preventive and Therapeutic Potential of Polyphenolic Nutraceuticals.
Sawikr Y; Yarla NS; Peluso I; Kamal MA; Aliev G; Bishayee A
Adv Protein Chem Struct Biol; 2017; 108():33-57. PubMed ID: 28427563
[TBL] [Abstract][Full Text] [Related]
44. Curcumin Ameliorates Neuroinflammation, Neurodegeneration, and Memory Deficits in p25 Transgenic Mouse Model that Bears Hallmarks of Alzheimer's Disease.
Sundaram JR; Poore CP; Sulaimee NHB; Pareek T; Cheong WF; Wenk MR; Pant HC; Frautschy SA; Low CM; Kesavapany S
J Alzheimers Dis; 2017; 60(4):1429-1442. PubMed ID: 29036814
[TBL] [Abstract][Full Text] [Related]
45. CHF5074 (CSP-1103) induces microglia alternative activation in plaque-free Tg2576 mice and primary glial cultures exposed to beta-amyloid.
Porrini V; Lanzillotta A; Branca C; Benarese M; Parrella E; Lorenzini L; Calzà L; Flaibani R; Spano PF; Imbimbo BP; Pizzi M
Neuroscience; 2015 Aug; 302():112-20. PubMed ID: 25450955
[TBL] [Abstract][Full Text] [Related]
46. Neuron-glia interactions as therapeutic targets in neurodegeneration.
Salmina AB
J Alzheimers Dis; 2009; 16(3):485-502. PubMed ID: 19276541
[TBL] [Abstract][Full Text] [Related]
47. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
Paouri E; Tzara O; Zenelak S; Georgopoulos S
J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
[TBL] [Abstract][Full Text] [Related]
48. Early intraneuronal amyloid triggers neuron-derived inflammatory signaling in APP transgenic rats and human brain.
Welikovitch LA; Do Carmo S; Maglóczky Z; Malcolm JC; Lőke J; Klein WL; Freund T; Cuello AC
Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6844-6854. PubMed ID: 32144141
[TBL] [Abstract][Full Text] [Related]
49. Altered calcium signaling and neuronal injury: stroke and Alzheimer's disease as examples.
Mattson MP; Rydel RE; Lieberburg I; Smith-Swintosky VL
Ann N Y Acad Sci; 1993 May; 679():1-21. PubMed ID: 8512177
[TBL] [Abstract][Full Text] [Related]
50. Amyloid-β pathology is attenuated by tauroursodeoxycholic acid treatment in APP/PS1 mice after disease onset.
Dionísio PA; Amaral JD; Ribeiro MF; Lo AC; D'Hooge R; Rodrigues CM
Neurobiol Aging; 2015 Jan; 36(1):228-40. PubMed ID: 25443293
[TBL] [Abstract][Full Text] [Related]
51. Intranasal interferon beta improves memory and modulates inflammatory responses in a mutant APP-overexpressing rat model of Alzheimer's disease.
Chavoshinezhad S; Mohseni Kouchesfahani H; Salehi MS; Pandamooz S; Ahmadiani A; Dargahi L
Brain Res Bull; 2019 Aug; 150():297-306. PubMed ID: 31233762
[TBL] [Abstract][Full Text] [Related]
52. Neuroprotective Effect of Alpha-Linolenic Acid against Aβ-Mediated Inflammatory Responses in C6 Glial Cell.
Lee AY; Lee MH; Lee S; Cho EJ
J Agric Food Chem; 2018 May; 66(19):4853-4861. PubMed ID: 29668263
[TBL] [Abstract][Full Text] [Related]
53. Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Blanco R; Carmona M; Ribera R; Goutan E; Puig B; Rey MJ; Cardozo A; Viñals F; Ribalta T
Brain Pathol; 2001 Apr; 11(2):144-58. PubMed ID: 11303790
[TBL] [Abstract][Full Text] [Related]
54. Interleukins, inflammation, and mechanisms of Alzheimer's disease.
Weisman D; Hakimian E; Ho GJ
Vitam Horm; 2006; 74():505-30. PubMed ID: 17027528
[TBL] [Abstract][Full Text] [Related]
55. Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology.
Mehlhorn G; Hollborn M; Schliebs R
Int J Dev Neurosci; 2000; 18(4-5):423-31. PubMed ID: 10817926
[TBL] [Abstract][Full Text] [Related]
56. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
[TBL] [Abstract][Full Text] [Related]
57. Glial Cells - The Key Elements of Alzheimer´s Disease.
Dzamba D; Harantova L; Butenko O; Anderova M
Curr Alzheimer Res; 2016; 13(8):894-911. PubMed ID: 26825092
[TBL] [Abstract][Full Text] [Related]
58. [Pro-inflammatory cytokines in Alzheimer's disease].
Stamouli EC; Politis AM
Psychiatriki; 2016; 27(4):264-275. PubMed ID: 28114090
[TBL] [Abstract][Full Text] [Related]
59. Retinal glial changes in Alzheimer's disease - A review.
Fernández-Albarral JA; Salobrar-García E; Martínez-Páramo R; Ramírez AI; de Hoz R; Ramírez JM; Salazar JJ
J Optom; 2019; 12(3):198-207. PubMed ID: 30377086
[TBL] [Abstract][Full Text] [Related]
60. A dual inhibitor of the proteasome catalytic subunits LMP2 and Y attenuates disease progression in mouse models of Alzheimer's disease.
Yeo IJ; Lee MJ; Baek A; Miller Z; Bhattarai D; Baek YM; Jeong HJ; Kim YK; Kim DE; Hong JT; Kim KB
Sci Rep; 2019 Dec; 9(1):18393. PubMed ID: 31804556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
